Prevalence and Risk Factors of Ocular Hypertension Following Fluocinolone Acetonide (Iluvien<sup>®</sup>) Intravitreal Injections: The "SAFAC" Study. [PDF]
Serrar Y +9 more
europepmc +1 more source
Discordance Among Patients and Ophthalmologists Regarding the Burden of Intravitreal Injections. [PDF]
Robinson K +4 more
europepmc +1 more source
Towards greener intravitreal injections: the Oxford Eye Hospital experience. [PDF]
Ong AY +5 more
europepmc +1 more source
Novel Needle for Intravitreal Injections Does Not Affect Biological Activity of Anti-VEGF Drugs. [PDF]
Lytvynchuk L +5 more
europepmc +1 more source
Topical Povidone Iodine 2.5% Versus 5% for Endophthalmitis Prophylaxis During Intravitreal Injections. [PDF]
Ajlan RS +6 more
europepmc +1 more source
Medical-nursing integrated service model in ophthalmic outpatient care for intravitreal injections: a retrospective cohort study. [PDF]
Lan G +6 more
europepmc +1 more source
Guiding syringe selection for intravitreal injections: injectability and stability analysis of compounded pegcetacoplan (SYFOVRE) and the broader implications for high-viscosity ophthalmic therapies. [PDF]
Felfeli T, Lane NM, Mandelcorn ED.
europepmc +1 more source
Outcomes of Ab-Interno Canaloplasty and Gonioscopy-Assisted Transluminal Trabeculotomy in Eyes with Sustained Intraocular Pressure Elevation Following Intravitreal Injections. [PDF]
Gallardo MJ +5 more
europepmc +1 more source
Tolerability of 0.5% Liposomal Ozonated Oil Versus 0.6% Povidone-Iodine in Antiseptic Prophylaxis for Intravitreal Injections. [PDF]
Pastore MR +7 more
europepmc +1 more source

